This brand name is authorized in Nigeria.
The drug MIC-CINE contains one active pharmaceutical ingredient (API):
1
|
UNII
4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
|
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
B4-2017 | Tablet | MIC-CINE TABLETS TAB 500 mg 1 X10 | MIC-CINE TABLETS CIPROFLOXACIN EACH FILM COATED TABLETS CONTAINS: CIPROFLOXACIN HYDROCHLORIDE USP EQUIVALENT TO CIPROFLOXACIN 500MG EXCIPIENTS Q.S APPROVED COLOUR USED. B4-2017 Drugs Imported Products 1 X10 Prescription Only Medicine (POM) 31/10/2022 MICPON PHARMACY LIMITED, UPPER KUTA ROAD SAIKO MINNA NIGER 0 micponpharmacy1@gmail.com JIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD,, NORTH ZONE, HIGH - NEW TECHNOLOGY INDUSTRIAL ZONE, PINGXIANG, JIANGXI, CHINA., China | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
J01MA02 | Ciprofloxacin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | B4-2017 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.